- How aromatase inhibitors and androgen deprivation therapy deplete bone mineral density
- The Calcium-D3-K2-Magnesium quartet — why all four must work together
- Why weight-bearing exercise is more powerful than supplements for bone protection
- How to use DEXA scans strategically and what T-scores mean
- When bisphosphonate drugs are appropriate and how to discuss them with your oncologist
Bone loss after cancer treatment is a silent threat. It produces no pain, no symptoms, and no warning — until a fracture occurs. For survivors on hormonal therapies, osteoporosis risk is not theoretical: it is a documented, measurable side effect that begins within months of starting treatment.
- Breast cancer survivors on aromatase inhibitors (anastrozole, letrozole, exemestane): These drugs suppress estrogen, which is the primary hormone that maintains bone density. BMD loss begins in the first 6–12 months.
- Prostate cancer patients on ADT (androgen deprivation therapy): Testosterone suppression removes bone-protective androgen signaling. BMD loss of 2–5% per year is common.
- All survivors who received long-term corticosteroids (as anti-nausea or anti-inflammatory agents) — steroids directly inhibit osteoblast activity.
- Survivors with premature menopause from chemotherapy (often in women under 45) — sudden estrogen loss is one of the most aggressive triggers of bone density reduction.
The Bone Health Nutrition Quartet
Target 1,000–1,200 mg/day from food: tempe, tofu, teri with bones, broccoli, spinach. Avoid high-dose supplements — excess calcium from pills, not food, increases arterial calcification risk.
Without D3, calcium is poorly absorbed from the gut. Best source: 15–20 min morning sun exposure (7–9 AM) without sunscreen. Supplement 1,000–4,000 IU/day if serum 25-OHD <30 ng/mL.
MK-7 form directs calcium absorbed from gut INTO bone matrix rather than into arterial walls. Critical companion to D3. Dose: 90–200 mcg MK-7/day. Found in natto, fermented cheese.
Weight-Bearing Exercise — More Powerful Than Supplements
Mechanical loading — the physical stress placed on bones during weight-bearing activity — is the primary stimulus for osteoblast (bone-building cell) activity. No supplement activates osteoblasts as powerfully as the simple act of standing and moving under your own body weight.
| Exercise Type | Bone Benefit | Cancer Survivor Notes |
|---|---|---|
| Walking (brisk, daily) | Loads hip, spine, and lower limb bones — highest fracture-risk areas | Start 15 min/day; build to 30–45 min. Best single habit for bone protection. |
| Stair climbing | Greater ground reaction force than level walking — higher osteogenic stimulus | Use handrail if CIPN; avoid if bone metastasis present |
| Single-leg standing | Intense loading of hip joint — prevents femoral neck fracture | Hold wall or chair if balance is impaired; start 10 sec/leg, build to 60 sec |
| Resistance training | Muscle pull on bones during contraction directly stimulates bone formation | Begin with body-weight exercises; add light resistance after 8 weeks |
| Restorative yoga / Tai Chi | Balance training reduces fall risk — most important for preventing fractures | Ideal cross-training; lower osteogenic stimulus but essential for fall prevention |
DEXA Scan — Understanding Your Bone Density Numbers
A DEXA scan (Dual-Energy X-ray Absorptiometry) measures your Bone Mineral Density (BMD) and reports it as a T-score — how your bone density compares to a healthy 30-year-old reference population.
| T-Score | Classification | Action Required |
|---|---|---|
| > -1.0 | Normal bone density | Continue prevention protocol; repeat scan in 2 years |
| -1.0 to -2.5 | Osteopenia (low bone mass) | Intensify nutrition and exercise protocol; discuss D3+K2+calcium with doctor; monitor annually |
| < -2.5 | Osteoporosis | Discuss bisphosphonate therapy (zoledronic acid or denosumab) with oncologist; enhanced fall prevention urgently |
| < -2.5 + prior fracture | Severe osteoporosis | Pharmacological intervention strongly indicated; comprehensive fall prevention program |
Bone Health Monitoring Log
| Parameter | Baseline Value | 6-Month Value | 12-Month Value | Doctor Notes |
|---|---|---|---|---|
| DEXA T-score (hip) | ||||
| DEXA T-score (lumbar spine) | ||||
| Serum Vitamin D (25-OHD) ng/mL | ||||
| Serum calcium | ||||
| Serum magnesium | ||||
| Estrogen / Testosterone level |
- Aromatase inhibitors and ADT begin depleting bone mineral density within the first 6–12 months — this is silent and requires proactive monitoring, not a wait-and-see approach.
- The bone protection quartet (Calcium + D3 + K2 + Magnesium) must work together — K2 ensures calcium goes to bone, not arteries; magnesium activates D3; all four are necessary.
- Weight-bearing exercise is the strongest osteoblast activator available — walking, stair climbing, and single-leg standing outperform any supplement at stimulating bone formation.
- Request a baseline DEXA scan before or within 3 months of starting hormonal therapy. Repeat annually. Know your T-score.
- Report new persistent back pain, height loss, or worsening posture — these can indicate vertebral compression fractures that require prompt evaluation.